Trial Profile
A multicentre randomised active controlled study comparing two schedules of radiotherapy or chemotherapy in elderly patients with high grade glioma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Jul 2022
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 06 Aug 2012 Primary endpoint 'Overall-survival-duration' has been met, based on results published in the Lancet Oncology.
- 06 Aug 2012 Final results published in the Lancet Oncology.
- 10 Mar 2010 New trial record